Results 41 to 50 of about 1,941,754 (312)

A Predictive Nomogram for Early Death in Pheochromocytoma and Paraganglioma

Frontiers in Oncology, 2022
BackgroundPheochromocytoma (PHEO) and paraganglioma (PGL) are relatively rare neuroendocrine tumors. The factors affecting patients with early death remain poorly defined. We aimed to study the demographic and clinicopathologic pattern and to develop and
Huiyang Li, Huiyang Li, Huiyang Li, Kirellos Said Abbas, Kirellos Said Abbas, Basel Abdelazeem, Basel Abdelazeem, Yao Xu, Yao Xu, Yile Lin, Haixiao Wu, Haixiao Wu, Vladimir P. Chekhonin, Vladimir P. Chekhonin, Karl Peltzer, Karl Peltzer, Chao Zhang, Chao Zhang   +17 more
doaj   +1 more source

Referral Patterns and Diagnostic Timeliness in Pediatric Cancer: A Hospital‐Based Study in Indonesia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Timely diagnosis and treatment are critical for improving survival among children with cancer. In low‐ and middle‐income countries (LMICs), delays are common and may be influenced by fragmented referral pathways and diagnostic limitations.
Nur Melani Sari, Regina Hadi Putri, Fatimah Assyifa, Judith Spijkerman, Gertjan Johannes Kaspers, Susi Susanah   +5 more
wiley   +1 more source

Prognostic Factors and Comprehensive Treatment of 95 Synovial Sarcoma Patients

Zhongliu Fangzhi Yanjiu, 2019
Objective To investigate prognostic factors and the efficacy of surgery-based comprehensive treatment for patients with synovial sarcoma. Methods We retrospectively analyzed the medical records of 95 synovial sarcoma patients.
TAO Fang, WANG Guowen, HAN Xiuxin, MA Yulin, ZHANG Chao, LI Lili   +5 more
doaj   +1 more source

Incidence, survival, and associated factors estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in Tianjin, China

BMC Cancer, 2023
Background Osteosarcoma is the most common primary malignant bone tumor. The current study was conducted to describe the general condition of patients with primary osteosarcoma in a single cancer center in Tianjin, China and to investigate the associated
Chao Zhang, Haixiao Wu, Guijun Xu, Yao Xu, Wenjuan Ma, Zhijun Li, Jin Zhang   +6 more
doaj   +1 more source

Venetoclax‐Based Therapy as a Bridge to Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Pediatric Acute Leukemia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Relapsed and/or refractory (R/R) pediatric acute leukemia carries a dismal prognosis, largely driven by chemoresistance to conventional salvage therapy. The BH3‐mimetic venetoclax, combined with chemotherapy or hypomethylating agents, has demonstrated efficacy in small clinical trials.
Katherine S. Colman, Deborah Meyran, Vajiranee Malalasekera, Heather Weerdenburg, Janine Campbell, Rachel Conyers, Stacie Wang, Hannah Walker, Seong Lin Khaw, Diane Hanna   +9 more
wiley   +1 more source

Tumors of bone

, 2015
Bone tumors constitute a heterogeneous group of neoplasms of skeletal origin. Benign cartilage tumors include osteochondroma, subungual exostosis, bizarre parosteal osteochondromatous proliferation (BPOP), chondromas, synovial chondromatosis ...
Mandahl, Nils,, Mertens, Fredrik,, Lund University.   +2 more
core   +2 more sources

Bone Mineral Density After Contemporary Treatment for Acute Lymphoblastic Leukaemia: A Matched Cross‐Sectional Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Reduced bone mineral density (BMD) has been reported in survivors of childhood and young adult acute lymphoblastic leukaemia (ALL); however, data from cohorts treated with contemporary protocols and including matched controls remain limited.
Karen Schow Jensen, Mette Tiedemann Skipper, Niels Holtum Birkebæk, Kjeld Schmiegelow, Thomas Leth Frandsen, Bente Langdahl, Rikke Beck Jensen, Asger Roer Pedersen, Christian Mølgaard, Liv Andrés‐Jensen, Birgitte Klug Albertsen   +10 more
wiley   +1 more source

[Primary malignant bone tumors].

, 2011
Among human neoplasms, primary malignant bone tumors are fairly rare. They present an incidence rate of roughly 10 cases per 1 million inhabitants per year. During childhood (
von Eisenhart-Rothe, R;Toepfer, A;Salzmann, M;Schauwecker, J;Gollwitzer, H;Rechl, H
core   +1 more source

Bone-Specific Enhancement of Antibody Therapy for Breast Cancer Metastasis to Bone

, 2022
Despite the rapid evolution of therapeutic antibodies, their clinical efficacy in the treatment of bone tumors is hampered due to the inadequate pharmacokinetics and poor bone tissue accessibility of these large macromolecules.
Ling Wu (151826), Zhan Xu (6239195), Han Xiao (373894), Ruchi Gupta (205155), Yuda Chen (5921747), Xiang H.-F. Zhang (9147414), Weijie Zhang (145595), Kuan-Lin Wu (1762933), Zeru Tian (11984077), Chenfei Yu (1586326), Chenhang Wang (11984080)   +10 more
core   +1 more source

Tumor dormancy in bone

Cancer Reports, 2019
AbstractBackgroundBone marrow is a common site of metastasis for a number of tumor types, including breast, prostate, and lung cancer, but the mechanisms controlling tumor dormancy in bone are poorly understood. In breast cancer, while advances in drug development, screening practices, and surgical techniques have dramatically improved survival rates ...
Vera Mayhew, Tolu Omokehinde, Rachelle W. Johnson   +2 more
openaire   +3 more sources